NRP1 and neoplasm: This formation leads to an increase in the p38 MAPK pathway, as Rho A and MAPK are interdependent, so when NRP1/GIPC1 are suppressed, there is a suppression observed in Rho A and MAPK, leading to loss of the ECS phenotype and reduction in the tumor growth [163].